Inventor · disambiguated record
Kenneth Brasel
Also filed as: BRASEL KENNETH · BRASEL KENNETH A · BRASEL KENNETH ALLAN
8 granted patents·9 pending applications·67 citations·filing 1999–2024
84Inventor score
Files withCENTURY THERAPEUTICS INC4AMGEN INC3BRASEL KENNETH ALLAN2KIRCHNER JACQUELINE A2HUTCHINSON FRED CANCER RES1
Top patents by PatentIndex Score
17 records- 0194US8182813B2Human C-FMS antigen binding proteinsBRASEL KENNETH ALLAN·Filed 2008·Granted May 22, 2012·34 cites·10 claims
- 0292US8513199B2Methods for treating conditions associated with c-fmsBRASEL KENNETH ALLAN·Filed 2012·Granted Aug 20, 2013·24 cites·13 claims
- 0377US8268311B2Human GM-CSF antigen binding proteinsKIRCHNER JACQUELINE A·Filed 2008·Granted Sep 18, 2012·5 cites·13 claims
- 0468US7150992B1Methods of preparing dendritic cells with flt3-ligand and antigenINNUNEX CORP·Filed 2000·Granted Dec 19, 2006·4 cites·5 claims
- 0568US2025059286A1Artificial cell death polypeptide for chimeric antigen receptor and uses thereofCENTURY THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0668US2009075886A1Dendritic cell stimulatory factorIMMUNEX CORP·Filed 2008·Application pending·0 cites
- 0767US12269888B2Artificial cell death polypeptide for chimeric antigen receptor and uses thereofCENTURY THERAPEUTICS INC·Filed 2023·Granted Apr 8, 2025·0 cites·4 claims
- 0862US9303084B2Human C-FMS antibodiesAMGEN INC·Filed 2013·Granted Apr 5, 2016·0 cites·10 claims
- 0961US2004037845A1Use of flt3-ligand in the treatment of infectionFiled 2003·Application pending·0 cites
- 1058US9988457B2Human C-FMS antigen binding proteinsAMGEN INC·Filed 2016·Granted Jun 5, 2018·0 cites·12 claims
- 1154US2008219985A1Prok2 antagonists and methods of useTHOMPSON PENNY J·Filed 2006·Application pending·0 cites
- 1252US8481704B2Nucleic acid molecule encoding human GM-CSF antigen binding proteinsKIRCHNER JACQUELINE A·Filed 2012·Granted Jul 9, 2013·0 cites·7 claims
- 1351US2013259799A1Human gm-csf antigen binding proteinsAMGEN INC·Filed 2013·Application pending·0 cites
- 1446US2022184123A1Genetically Engineered Cells and Uses ThereofCENTURY THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1546US2022143210A1Hydrogel compositions and methods for treatement of malignanciesHUTCHINSON FRED CANCER RES·Filed 2020·Application pending·0 cites
- 1646US2022195396A1Genetically Engineered Cells and Uses ThereofCENTURY THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1729US2002034517A1Dendritic cell stimulatory factorFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kenneth Brasel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →